drugset / Trial / NCT01628666
Prevention of Arrhythmia Device Infection Trial (PADIT)
Phase 4
Completed
12814 enrolled
Population Health Research Institute
Canadian Institutes of Health Research (CIHR) · collab
RandomizedCrossoverOpen-labelPrevention
Summary
The goal of the study is to compare whether a center-wide policy of incremental antibiotic therapy will reduce CIED infection rate compared to a policy of conventional antibiotic prophylaxis in high-risk patients undergoing arrhythmia device procedures. All antibiotics used are approved for use and readily available.
Timeline
- Start
- 2012-12
- Primary completion
- 2017-09-08
- Completion
- 2017-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bacitracin | Unknown | — | — |
| Subject | CEPHALEXIN ANHYDROUS | Small molecule | — | — |
| Subject | Vancomycin | Other / unclassified | — | — |
| Background | Cefazolin | Small molecule | — | — |